Literature DB >> 21217684

Defying malaria: Arming T cells to halt malaria.

Michael F Good1, Christian Engwerda.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21217684     DOI： 10.1038/nm0111-49

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

Review 1.  Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research.

Authors:  Michael F Good; Huji Xu; Michelle Wykes; Christian R Engwerda
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

2.  Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice.

Authors:  Alberto Pinzon-Charry; Virginia McPhun; Vivian Kienzle; Chakrit Hirunpetcharat; Christian Engwerda; James McCarthy; Michael F Good
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

3.  Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites.

Authors:  L Schofield; J Villaquiran; A Ferreira; H Schellekens; R Nussenzweig; V Nussenzweig
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria.

Authors:  Salenna R Elliott; Rachel D Kuns; Michael F Good
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

5.  Cellular subsets involved in cell-mediated immunity to murine Plasmodium yoelii 17X malaria.

Authors:  R J Mogil; C L Patton; D R Green
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

6.  Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

Authors:  David J Pombo; Gregor Lawrence; Chakrit Hirunpetcharat; Christine Rzepczyk; Michelle Bryden; Nicole Cloonan; Karen Anderson; Yuvadee Mahakunkijcharoen; Laura B Martin; Danny Wilson; Salenna Elliott; Suzanne Elliott; Damon P Eisen; J Brice Weinberg; Allan Saul; Michael F Good
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

7.  T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii.

Authors:  A N Jayawardena; D B Murphy; C A Janeway; R K Gershon
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

8.  Adoptive protection against Plasmodium chabaudi adami malaria in athymic nude mice by a cloned T cell line.

Authors:  D A Brake; C A Long; W P Weidanz
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

9.  Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.

Authors:  Takashi Imai; Jianying Shen; Bin Chou; Xuefeng Duan; Liping Tu; Kohhei Tetsutani; Chikako Moriya; Hidekazu Ishida; Shinjiro Hamano; Chikako Shimokawa; Hajime Hisaeda; Kunisuke Himeno
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

10.  Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria.

Authors:  J M Vinetz; S Kumar; M F Good; B J Fowlkes; J A Berzofsky; L H Miller
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422
View more
  14 in total

Review 1.  Revealing the molecular signatures of host-pathogen interactions.

Authors:  Chiea-Chuen Khor; Martin L Hibberd
Journal:  Genome Biol       Date:  2011-10-19       Impact factor: 13.583

2.  Host immune response is severely compromised during lethal Plasmodium vinckei infection.

Authors:  Jyoti Bhardwaj; Arif Jamal Siddiqui; Manish Goyal; Kirtika Prakash; Awakash Soni; Sunil K Puri; Mrigank Srivastava
Journal:  Parasitol Res       Date:  2015-06-17       Impact factor: 2.289

3.  Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.

Authors:  Sumi Biswas; Alexandra J Spencer; Emily K Forbes; Sarah C Gilbert; Anthony A Holder; Adrian V S Hill; Simon J Draper
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

4.  Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.

Authors:  Susanne H Sheehy; Christopher J A Duncan; Sean C Elias; Katharine A Collins; Katie J Ewer; Alexandra J Spencer; Andrew R Williams; Fenella D Halstead; Samuel E Moretz; Kazutoyo Miura; Christian Epp; Matthew D J Dicks; Ian D Poulton; Alison M Lawrie; Eleanor Berrie; Sarah Moyle; Carole A Long; Stefano Colloca; Riccardo Cortese; Sarah C Gilbert; Alfredo Nicosia; Adrian V S Hill; Simon J Draper
Journal:  Mol Ther       Date:  2011-08-23       Impact factor: 11.454

5.  Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection.

Authors:  Sean C Elias; Katharine A Collins; Fenella D Halstead; Prateek Choudhary; Carly M Bliss; Katie J Ewer; Susanne H Sheehy; Christopher J A Duncan; Sumi Biswas; Adrian V S Hill; Simon J Draper
Journal:  J Immunol       Date:  2013-01-04       Impact factor: 5.422

6.  Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.

Authors:  Sumi Biswas; Matthew D J Dicks; Carole A Long; Edmond J Remarque; Loredana Siani; Stefano Colloca; Matthew G Cottingham; Anthony A Holder; Sarah C Gilbert; Adrian V S Hill; Simon J Draper
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

7.  Cytotoxic activities of CD8⁺ T cells collaborate with macrophages to protect against blood-stage murine malaria.

Authors:  Takashi Imai; Hidekazu Ishida; Kazutomo Suzue; Tomoyo Taniguchi; Hiroko Okada; Chikako Shimokawa; Hajime Hisaeda
Journal:  Elife       Date:  2015-03-11       Impact factor: 8.140

8.  ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.

Authors:  Susanne H Sheehy; Christopher J A Duncan; Sean C Elias; Prateek Choudhary; Sumi Biswas; Fenella D Halstead; Katharine A Collins; Nick J Edwards; Alexander D Douglas; Nicholas A Anagnostou; Katie J Ewer; Tom Havelock; Tabitha Mahungu; Carly M Bliss; Kazutoyo Miura; Ian D Poulton; Patrick J Lillie; Richard D Antrobus; Eleanor Berrie; Sarah Moyle; Katherine Gantlett; Stefano Colloca; Riccardo Cortese; Carole A Long; Robert E Sinden; Sarah C Gilbert; Alison M Lawrie; Tom Doherty; Saul N Faust; Alfredo Nicosia; Adrian V S Hill; Simon J Draper
Journal:  Mol Ther       Date:  2012-10-23       Impact factor: 11.454

9.  Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.

Authors:  Susanne H Sheehy; Christopher J A Duncan; Sean C Elias; Sumi Biswas; Katharine A Collins; Geraldine A O'Hara; Fenella D Halstead; Katie J Ewer; Tabitha Mahungu; Alexandra J Spencer; Kazutoyo Miura; Ian D Poulton; Matthew D J Dicks; Nick J Edwards; Eleanor Berrie; Sarah Moyle; Stefano Colloca; Riccardo Cortese; Katherine Gantlett; Carole A Long; Alison M Lawrie; Sarah C Gilbert; Tom Doherty; Alfredo Nicosia; Adrian V S Hill; Simon J Draper
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

10.  Differential immune response associated to malaria outcome is detectable in peripheral blood following Plasmodium yoelii infection in mice.

Authors:  Isabel G Azcárate; Patricia Marín-García; Alí N Kamali; Susana Pérez-Benavente; Antonio Puyet; Amalia Diez; José M Bautista
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.